BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20635112)

  • 1. Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration.
    Mandolesi G; Grasselli G; Musumeci G; Centonze D
    Neurol Sci; 2010 Nov; 31(Suppl 2):S255-9. PubMed ID: 20635112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.
    Ziehn MO; Avedisian AA; Tiwari-Woodruff S; Voskuhl RR
    Lab Invest; 2010 May; 90(5):774-86. PubMed ID: 20157291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
    Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
    J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration and inflammation in hippocampus in experimental autoimmune encephalomyelitis induced in rats by one--time administration of encephalitogenic T cells.
    Kurkowska-Jastrzębska I; Swiątkiewicz M; Zaremba M; Cudna A; Piechal A; Pyrzanowska J; Widy-Tyszkiewicz E; Członkowska A
    Neuroscience; 2013 Sep; 248():690-8. PubMed ID: 23806721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis.
    Centonze D; Muzio L; Rossi S; Cavasinni F; De Chiara V; Bergami A; Musella A; D'Amelio M; Cavallucci V; Martorana A; Bergamaschi A; Cencioni MT; Diamantini A; Butti E; Comi G; Bernardi G; Cecconi F; Battistini L; Furlan R; Martino G
    J Neurosci; 2009 Mar; 29(11):3442-52. PubMed ID: 19295150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
    Gentile A; Musella A; Bullitta S; Fresegna D; De Vito F; Fantozzi R; Piras E; Gargano F; Borsellino G; Battistini L; Schubart A; Mandolesi G; Centonze D
    J Neuroinflammation; 2016 Aug; 13(1):207. PubMed ID: 27566665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegeneration in autoimmune CNS inflammation.
    Herz J; Zipp F; Siffrin V
    Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis.
    Musella A; Gentile A; Guadalupi L; Rizzo FR; De Vito F; Fresegna D; Bruno A; Dolcetti E; Vanni V; Vitiello L; Bullitta S; Sanna K; Caioli S; Balletta S; Nencini M; Buttari F; Stampanoni Bassi M; Centonze D; Mandolesi G
    Cells; 2020 May; 9(5):. PubMed ID: 32455907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1β dependent cerebellar synaptopathy in a mouse mode of multiple sclerosis.
    Mandolesi G; Gentile A; Musella A; Centonze D
    Cerebellum; 2015 Feb; 14(1):19-22. PubMed ID: 25326653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis.
    Bourel J; Planche V; Dubourdieu N; Oliveira A; Séré A; Ducourneau EG; Tible M; Maitre M; Lesté-Lasserre T; Nadjar A; Desmedt A; Ciofi P; Oliet SH; Panatier A; Tourdias T
    Neurobiol Dis; 2021 Dec; 160():105533. PubMed ID: 34673149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.
    Nisticò R; Mori F; Feligioni M; Nicoletti F; Centonze D
    Philos Trans R Soc Lond B Biol Sci; 2014 Jan; 369(1633):20130162. PubMed ID: 24298163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.
    Nisticò R; Mango D; Mandolesi G; Piccinin S; Berretta N; Pignatelli M; Feligioni M; Musella A; Gentile A; Mori F; Bernardi G; Nicoletti F; Mercuri NB; Centonze D
    PLoS One; 2013; 8(1):e54666. PubMed ID: 23355887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis.
    Centonze D; Muzio L; Rossi S; Furlan R; Bernardi G; Martino G
    Cell Death Differ; 2010 Jul; 17(7):1083-91. PubMed ID: 19927157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype.
    Hou B; Zhang Y; Liang P; He Y; Peng B; Liu W; Han S; Yin J; He X
    Cell Death Dis; 2020 May; 11(5):377. PubMed ID: 32415059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental models of relapsing-remitting multiple sclerosis: current concepts and perspective.
    Skundric DS
    Curr Neurovasc Res; 2005 Oct; 2(4):349-62. PubMed ID: 16181126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis.
    Soellner IA; Rabe J; Mauri V; Kaufmann J; Addicks K; Kuerten S
    Clin Immunol; 2013 Dec; 149(3):519-29. PubMed ID: 24239839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent activation of microglia and NADPH oxidase [corrected] drive hippocampal dysfunction in experimental multiple sclerosis.
    Di Filippo M; de Iure A; Giampà C; Chiasserini D; Tozzi A; Orvietani PL; Ghiglieri V; Tantucci M; Durante V; Quiroga-Varela A; Mancini A; Costa C; Sarchielli P; Fusco FR; Calabresi P
    Sci Rep; 2016 Feb; 6():20926. PubMed ID: 26887636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Microglial Activity and Enhanced Glutamate Transmission in the Basolateral Amygdala in Early CNS Autoimmunity.
    Acharjee S; Verbeek M; Gomez CD; Bisht K; Lee B; Benoit L; Sharkey KA; Benediktsson A; Tremblay ME; Pittman QJ
    J Neurosci; 2018 Oct; 38(42):9019-9033. PubMed ID: 30185466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
    Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM
    Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis.
    Guadalupi L; Mandolesi G; Vanni V; Balletta S; Caioli S; Pavlovic A; De Vito F; Fresegna D; Sanna K; Vitiello L; Nencini M; Tartacca A; Mariani F; Rovella V; Schippling S; Ruf I; Collin L; Centonze D; Musella A
    Neuropharmacology; 2024 Jul; 252():109940. PubMed ID: 38570068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.